Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms Teams With SAS on Analysis of Genomic, Other Patient Data

NEW YORK – BC Platforms said on Tuesday that it has partnered with analytics giant SAS Institute to provide life sciences and healthcare organizations with curated genomics and other patient data. The companies expect that the partnership will help them break down data silos and ultimately improve prediction of health outcomes.

Zurich-based BC Platforms and Cary, North Carolina-based SAS said that they already have many of the same clients in pharmaceutical development and healthcare delivery. The firms said they will "discover new ways to derive insights" from genomics and other patient data, such as imaging and blood chemistry.

"Big data is not close to reaching its full potential in health," Nino da Silva, deputy managing director for BC Platforms, said in a statement. "But through our partnership, which provides access to carefully curated patient data, including genomic data, we will deliver tangible results that will make a difference to drug development, healthcare provision, and patient outcomes."

Scott McClain, principal industry consultant at SAS, added that the partnership "ensures users get closer to the high-quality genomics and real-world data networks they need to make bold discoveries that drive progress."

The new collaboration adds to BC Platforms' other recent partnerships, including with Singapore Health Services, the African Institute of Everyone Genome, and Cure Duchenne.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.